Sugiyama Kazuhisa, Ijiri Shigeyuki, Tagawa Shigeki, Shimizu Koichi
Department of Ophthalmology and Visual Sciences, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Department of Ophthalmology and Visual Science, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Jpn J Ophthalmol. 2009 Mar;53(2):81-91. doi: 10.1007/s10384-009-0650-2. Epub 2009 Mar 31.
Takayasu disease was first reported in 1908 by Mikito Takayasu as "a case of peculiar changes in the central retinal vessels." Because in these patients the pulse of the radial artery is impalpable, investigations focusing on the ischemic symptoms of the upper body were conducted. In 1948, Shimizu and Sano named this pathological condition "pulseless disease." Since then, the lesions of Takayasu disease have been detected not only in the aortic arch and its main branches but also in various vessels, including the abdominal aorta and renal arteries. The ocular symptoms of Takayasu disease are considered to be due to ischemia in the retina and choroid. The typical wreath-like arteriovenous anastomosis around the disc reported by Takayasu is observed at a relatively late stage of the disease. The characteristic fundus findings of Takayasu disease include tortuosity and dilatation of the central retinal artery and vein, retinal arteriovenous anastomosis, prominent retinal vasculature, microaneurysms in the capillaries, occlusion of retinal arterioles, soft exudate, choked disc, and optic atrophy. Fluorescein angiography reveals retinal microaneurysms, sludging, slower blood flow, dilatation of retinal vessels, leakage of fluorescence dye due to increased vascular permeability, and arteriovenous anastomosis. Arteriovenous anastomosis initially appears in the periphery at the early stage, and in the arteriovenous crossing at the advanced stage. Systemic administration of corticosteroids is required to prevent vascular stenosis during the early stages of Takayasu disease. Reconstruction of the carotid artery may improve subjective symptoms and fundus findings.
1908年,高田富雄首次报告了高安氏病,称其为“一例视网膜中央血管的特殊变化”。由于这些患者的桡动脉搏动无法触及,因此针对上半身缺血症状展开了研究。1948年,清水和佐野将这种病理状况命名为“无脉症”。从那时起,高安氏病的病变不仅在主动脉弓及其主要分支中被检测到,还在包括腹主动脉和肾动脉在内的各种血管中被发现。高安氏病的眼部症状被认为是由于视网膜和脉络膜缺血所致。高安氏报告的视盘周围典型的花环样动静脉吻合在疾病相对晚期才会出现。高安氏病的特征性眼底表现包括视网膜中央动脉和静脉迂曲、扩张,视网膜动静脉吻合,视网膜血管明显,毛细血管微动脉瘤,视网膜小动脉阻塞,软性渗出,视盘水肿和视神经萎缩。荧光素血管造影显示视网膜微动脉瘤、血流淤滞、血流缓慢、视网膜血管扩张、血管通透性增加导致荧光染料渗漏以及动静脉吻合。动静脉吻合在早期出现在周边,在晚期出现在动静脉交叉处。在高安氏病早期需要全身应用皮质类固醇以预防血管狭窄。颈动脉重建可能会改善主观症状和眼底表现。